Goldman Sachs Group Inc Prothena Corp Public LTD CO Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 510,462 shares of PRTA stock, worth $2.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
510,462
Previous 510,462
-0.0%
Holding current value
$2.58 Million
Previous $6.32 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding PRTA
# of Institutions
185Shares Held
43.7MCall Options Held
251KPut Options Held
79.2K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$58.6 Million11.27% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$26.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$19.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.46MShares$17.5 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$11.1 Million0.41% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $237M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...